Gene:
GATA6
GATA binding protein 6

PharmGKB contains no dosing guidelines for this . To report known genotype-based dosing guidelines, or if you are interested in developing guidelines, click here.

PharmGKB contains no drug labels with pharmacogenomic information for this . To report a drug label with PGx, click here.

Disclaimer: The PharmGKB's clinical annotations reflect expert consensus based on clinical evidence and peer-reviewed literature available at the time they are written and are intended only to assist clinicians in decision-making and to identify questions for further research. New evidence may have emerged since the time an annotation was submitted to the PharmGKB. The annotations are limited in scope and are not applicable to interventions or diseases that are not specifically identified.

The annotations do not account for individual variations among patients, and cannot be considered inclusive of all proper methods of care or exclusive of other treatments. It remains the responsibility of the health-care provider to determine the best course of treatment for a patient. Adherence to any guideline is voluntary, with the ultimate determination regarding its application to be made solely by the clinician and the patient. PharmGKB assumes no responsibility for any injury or damage to persons or property arising out of or related to any use of the PharmGKB clinical annotations, or for any errors or omissions.

? = Mouse-over for quick help

This is a non-comprehensive list of genetic tests with pharmacogenetics relevance, typically submitted by the manufacturer and manually curated by PharmGKB. The information listed is provided for educational purposes only and does not constitute an endorsement of any listed test or manufacturer.

A more complete listing of genetic tests is found at the Genetic Testing Registry (GTR).

PGx Test Variants Assayed Related Drugs?

Overview

Alternate Names:  None
Alternate Symbols:  None
PharmGKB Accession Id: PA28589

Details

Cytogenetic Location: chr18 : q11.1 - q11.2
GP mRNA Boundary: chr18 : 19749416 - 19782227
GP Gene Boundary: chr18 : 19739416 - 19785227
Strand: plus
The mRNA boundaries are calculated using the gene's default feature set from NCBI, mapped onto the UCSC Golden Path. PharmGKB sets gene boundaries by expanding the mRNA boundaries by no less than 10,000 bases upstream (5') and 3,000 bases downstream (3') to allow for potential regulatory regions.

Publications related to GATA6: 1

No Dosing Guideline available No Drug Label available No Clinical Annotation available No Variant Annotation available No VIP available No VIP available
T-13910 DNA variant associated with lactase persistence interacts with Oct-1 and stimulates lactase promoter activity in vitro. Human molecular genetics. 2005. Lewinsky Rikke H, et al. PubMed

LinkOuts

Entrez Gene:
2627
OMIM:
601656
UCSC Genome Browser:
NM_005257
RefSeq RNA:
NM_005257
RefSeq Protein:
NP_005248
RefSeq DNA:
AC_000061
AC_000150
NC_000018
NT_010966
NW_001838467
NW_927095
UniProtKB:
Q05CA6_HUMAN (Q05CA6)
GATA6_HUMAN (Q92908)
Ensembl:
ENSG00000141448
GenAtlas:
GATA6
GeneCard:
GATA6
MutDB:
GATA6
ALFRED:
LO028736A
HuGE:
GATA6
Comparative Toxicogenomics Database:
2627
ModBase:
Q92908
HumanCyc Gene:
HS06830
HGNC:
4174

Common Searches